Long-Term: Sustained anti-inflammatory effects, improved joint comfort, and ongoing protection of muscles, connective tissue, and digestive health with continued therapy.
This dual functionality explains much of GHK-Cu's versatilityit's not just providing copper to cells, it's also telling them what to do with it
The rate of weight loss tends to be higher in the initial months as the body adjusts to the medication and the effects on appetite and metabolism take hold
Bioorganic & medicinal chemistry, 26 (10), 2700-2707
X., Stambas, J., Selemidis, S., Crack, P
The SURMOUNT-5 trial showed tirzepatide produces about 47% more weight loss than semaglutide on average, which is 20.2% versus 13.7% body weight reduction over 72 weeks